Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Allena Pharmaceuticals Inc (NQ: ALNA )

1.480 USD -0.070 (-4.52%)
Official Closing Price Updated: 7:55 PM EST, Jan 15, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press releases about Allena Pharmaceuticals Inc

< Previous 1 2 Next >
Allena Pharmaceuticals to Present at Upcoming Investor Conferences in January
From GlobeNewswire News Releases
Allena Pharmaceuticals Increases Previously Announced Bought Deal to $13.0 Million
From GlobeNewswire News Releases
Allena Pharmaceuticals Announces $10.0 Million Bought Deal Offering
From GlobeNewswire News Releases
Allena Pharmaceuticals Announces Appointment of David J. Clark, M.D., M.R.C.P. as Chief Medical Officer
From GlobeNewswire News Releases
Allena Pharmaceuticals Announces Initial Data from Phase 1 Trial of ALLN-346
From GlobeNewswire News Releases
Allena Pharmaceuticals to Present Virtually at Evercore ISI 3rd Annual HealthCONx Conference
From GlobeNewswire News Releases
Allena Pharmaceuticals Announces Third Quarter 2020 Financial Results and Provides Business Update
From GlobeNewswire News Releases
Allena Pharmaceuticals to Participate Virtually in Upcoming Investor Conferences in November
From GlobeNewswire News Releases
Noveome Biotherapeutics, Inc. Announces New Appointments to its Board of Directors
Noveome Biotherapeutics, Inc., a clinical stage biopharmaceutical company focused on developing next-generation biologics for the restoration of cellular integrity of damaged tissues, has appointed M.... 
From Business Wire News Releases
Allena Pharmaceuticals Appoints Ann Miller, M.D. to its Board of Directors
From GlobeNewswire News Releases
Thinking about buying stock in Iterum Therapeutics, FuelCell Energy, Allena Pharmaceuticals, General Electric, or Sorrento Therapeutics?
InvestorsObserver issues critical PriceWatch Alerts for ITRM, FCEL, ALNA, GE, and SRNE. 
From PR Newswire
Allena Pharmaceuticals Announces $25 Million Strategic Convertible Debt Financing Agreement with Pontifax Ventures
From GlobeNewswire News Releases
Allena Pharmaceuticals Doses First Subject in Phase 1 Clinical Trial of ALLN-346, in Development for the Treatment of Hyperuricemia in Patients with Gout and Advanced Chronic Kidney Disease
Initial Data Expected in the Fourth Quarter of 2020 
From GlobeNewswire News Releases
Allena Pharmaceuticals to Present Virtually at Upcoming Investor Conferences in September
From GlobeNewswire News Releases
Allena Pharmaceuticals Announces Second Quarter 2020 Financial Results and Provides Business Update
From GlobeNewswire News Releases
Allena Pharmaceuticals to Present at 2020 Wedbush PacGrow Healthcare Virtual Conference
From GlobeNewswire News Releases
Allena Pharmaceuticals Increases Previously Announced Bought Deal to $6.7 Million
From GlobeNewswire News Releases
Allena Pharmaceuticals Announces $5.0 Million Bought Deal Offering
From GlobeNewswire News Releases
U.S. Small Cap Stocks Could Outperform The Market During The Recovery And Here Are Four Stocks You Need To Know About
OTC Stock Review Market Commentary 
From GlobeNewswire News Releases
Allena Pharmaceuticals Announces $15.0 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules
From GlobeNewswire News Releases
Thinking about buying stock in Tenax Therapeutics, Allena Pharmaceuticals, Trevena, Adaptimmune Therapeutics, or Aurora Cannabis?
InvestorsObserver issues critical PriceWatch Alerts for TENX, ALNA, TRVN, ADAP, and ACB. 
From PR Newswire
Allena Pharmaceuticals to Present at Jefferies Virtual Healthcare Conference
From GlobeNewswire News Releases
Allena Pharmaceuticals Reports First Quarter 2020 Financial Results and Provides Business Update
From GlobeNewswire News Releases
Allena Pharmaceuticals Reports Fourth Quarter 2019 and Full Year 2019 Financial Results and Provides Business Update
From GlobeNewswire News Releases
Allena Pharmaceuticals to Present at 40th Annual Cowen & Co. Health Care Conference
From GlobeNewswire News Releases
Allena Pharmaceuticals Announces Streamlined Design for URIROX-2, Second Pivotal Clinical Trial of Reloxaliase for Enteric Hyperoxaluria
From GlobeNewswire News Releases
Allena Pharmaceuticals Provides Updates on Reloxaliase Development Program and Corporate Activities
From GlobeNewswire News Releases
Allena Pharmaceuticals to Present at Evercore ISI 2nd Annual HEALTHCONx Conference
From GlobeNewswire News Releases
Allena Pharmaceuticals Reports Third Quarter 2019 Financial Results and Provides Business Update
From GlobeNewswire News Releases
Allena Pharmaceuticals Reports Positive Reloxaliase Topline Results from URIROX-1 Trial and from Study 206
From GlobeNewswire News Releases
< Previous 1 2 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.